Alkem reports an Amendment cum Supplemental Agreement for Enzene’s private placement to F-Prime and ERVI, with updated shareholding and a Rs 26.16 crore infusion; details disclosed under SEBI LODR.
AI Assistant
Alkem Laboratories Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.